Dr. Aaron Michael Wolfson, MD

Dr. Wolfson practices at Keck Hospital of USC in Los Angeles, California, part of University of Southern California.

Dr. Wolfson's NPI, 1144584913, was assigned on June 27, 2012. Dr. Wolfson graduated from Boston University School Of Medicine in 2012. Dr. Wolfson holds California license A135685.

Dr. Wolfson's primary practice is Keck Hospital of USC, at 1500 San Pablo Street, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 442-8656.

Dr. Wolfson's primary practice is Keck Hospital of USC in Los Angeles, California, part of University of Southern California. Dr. Wolfson is also affiliated with Los Angeles General Medical Center. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Wolfson to 2 more hospitals, 1 group practice or clinic, 1 other site and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wolfson practices, 7 sites in all. Vendor and product names are available with a free account.

Advanced heart failure and transplant cardiology is Dr. Wolfson's primary specialty in the NPI Registry, under taxonomy code 207RA0001X. Dr. Wolfson is board certified in advanced heart failure and transplant cardiology by the American Board of Internal Medicine. Dmand AI has Dr. Wolfson's licenses on file in 4 states: California, Nevada, Arizona and Illinois.

Dmand AI lists cardiomyopathy, congestive heart failure, fluid and electrolyte imbalances and heart failure among the conditions Dr. Wolfson treats.

CMS data shows 1,292 Medicare services from Dr. Wolfson across 12 procedure codes in 2024, for 429 Medicare patients. Medicare paid $111,993 for them.

CMS counts 429 Medicare patients who saw Dr. Wolfson in 2024. The largest group is 65 to 74, with 186 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 57% are also on Medicaid. Their average risk score is 3.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wolfson's median patient age at 62, with 36% women.

In 2024, Dr. Wolfson wrote 302 Medicare Part D claims for 82 patients. 72% of them were for generic drugs. CMS names the drug for 195 of them, across 11 drugs with 11 or more claims each, at $456,971 in total drug cost. In 2023, CMS named 272 claims across 12 drugs.

Dr. Wolfson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wolfson as offering telehealth.

Dmand AI links 13 papers to Dr. Wolfson, published from 2014 to 2025. 2018 was the busiest year, with 2. Dr. Wolfson's most frequent co-authors are David Mark Shavelle, MD, Joseph Esaum Rahman, MD and Craig J. Baker, MD.

Dmand AI links Dr. Wolfson to 1 clinical trial. Conditions studied include Fibromatosis, Gingival, 2 and Heart Failure.

CMS Open Payments shows 131 general payments to Dr. Wolfson from 18 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 75% of the total. Abbott Laboratories paid the most, $14,183.

Dr. Wolfson graduated from Boston University School Of Medicine in 2012.

Dr. Wolfson is in network with 6 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.